Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions
email article Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported. Several valve repair and replacement technologies, designed as alternatives to surgery in high-risk patients, had promising early results presented at this year's virtual European Association of Percutaneous Cardiovascular Interventions (EuroPCR) meeting. The larger pivotal trials for these devices are not expected to be completed for at least another few years. As such, the following all remain investigational devices in the U....